UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------------
OMB APPROVAL
------------------------------------
OMB Number: 3235-0145
Expires: August 31, 1999
Estimated average burden
hours per response........14.90
------------------------------------
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)*
Arterial Vascular Engineering, Inc.
-----------------------------------
(Name of Issuer)
Common Stock
------------
(Title of Class of Securities)
043013-10-1
-----------
(CUSIP Number)
-------------------------------------------------------
(Date of Event Which Requires Filing of This Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[X] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Potential persons who are to respond to the collection of information contained
in this form are not required to respond unless the form displays a currently
valid OMB control number.
Page 1 of 4
<PAGE>
<TABLE>
<CAPTION>
------------------------------------------ --------------------------------------
CUSIP No. 043013-10-1 13G Page 2 of 4 Pages
------------------------------------------ --------------------------------------
<S> <C>
---------- --------------------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
I.R.S. IDENTIFICATION NO(S). OF ABOVE PERSON(S) (ENTITIES ONLY)
John D. Miller SSN ###-##-####
---------- --------------------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) Not Applicable
(b)
---------- --------------------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
---------- --------------------------------------------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
---------- --------------------------------------------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 3,655,696*
BENEFICIALLY ----- -------------------------------------------------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH -0-
REPORTING ----- -------------------------------------------------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH: 3,655,696*
----- -------------------------------------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
-0-
---------- --------------------------------------------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,655,696*
---------- --------------------------------------------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
---------- --------------------------------------------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
5.6%
---------- --------------------------------------------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
---------- --------------------------------------------------------------------------------------------------------------------
</TABLE>
Page 2 of 4
<PAGE>
<TABLE>
<CAPTION>
Item 1.
<S> <C> <C>
(a) Name of Issuer Arterial Vascular Engineering, Inc.
(b) Address of Issuer's Principal Executive Offices 3576 Unocal Place
Santa Rosa, CA 95403
Item 2.
(a) Name of Person Filing John D. Miller
(b) Address of Principal Business Office or, if none, Residence 3576 Unocal Place
Santa Rosa, CA 95403
(c) Citizenship United States
(d) Title of Class of Securities Common Stock
(e) CUSIP Number 043013-10-1
Item 3. If this statement is filed pursuant to ss.ss.240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
Not Applicable
(a) [ ] Broker or Dealer registered under Section 15 of the Act (15 U.S.C. 78o);
(b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c) [ ] Insurance company as defined in section 3(a)19) of the Act (15 U.S.C. 78c);
(d) [ ] An investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e) [ ] An investment adviser in accordance with ss.240.13d-1(b)(1)(ii)(F);
(f) [ ] An employee benefit plan or endowment fund in accordance withss.240.13d-1(b)(1)(ii)(F);
(g) [ ] A parent holding company or control person in accordance withss.240.13d-1(b)(ii)(G);
(h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i) [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of
the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J)
Item 4. Ownership
Provide the following information regarding the aggregate number and percentage of the class of securities of the
issuer identified in Item 1.
(a) Amount Beneficially Owned: 3,655,696*
(b) Percent of Class: 5.6%
(c) Number of shares as to which such person has:
(i) Sole power to vote or to direct the vote: 3,655,696*
(ii) Shared power to vote or to direct the vote: -0-
(iii) Sole power to dispose or to direct the disposition of: 3,655,696*
(iv) Shared power to dispose or to direct the disposition of: -0-
*Includes 707,534 shares held by family trusts for which Doreen D. Miller (Mr. Miller's spouse) and J.P. Morgan California are
co-trustees and as to which shares Mr. Miller disclaims beneficial ownership, and includes 16,000 shares held by a foundation of
which John D. Miller and Doreen D. Miller are co-trustees and as to which shares Mr. Miller disclaims beneficial ownership.
Item 5. Ownership of Five Percent or Less of a Class
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be
the beneficial owner of more than five percent of the class of securities, check the following [X].
Item 6. Ownership of More than Five Percent on Behalf of Another Person
Not Applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding
Company
Not Applicable.
</TABLE>
Page 3 of 4
<PAGE>
Item 8. Identification and Classification of Members of the Group
Not Applicable.
Item 9. Notice of Dissolution of a Group
Not Applicable.
Item 10. Certification Not Applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 12, 1999
----------------------------------------
Date
/s/ John D. Miller
----------------------------------------
Signature
John D. Miller
----------------------------------------
Name/Title
Page 4 of 4
